LU83343A1 - Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose,et preparations ainsi obtenues - Google Patents
Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose,et preparations ainsi obtenues Download PDFInfo
- Publication number
- LU83343A1 LU83343A1 LU83343A LU83343A LU83343A1 LU 83343 A1 LU83343 A1 LU 83343A1 LU 83343 A LU83343 A LU 83343A LU 83343 A LU83343 A LU 83343A LU 83343 A1 LU83343 A1 LU 83343A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- cells
- mice
- toxoplasmas
- inoculated
- infected
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000003745 diagnosis Methods 0.000 title abstract description 5
- 201000005485 Toxoplasmosis Diseases 0.000 title abstract description 4
- 241000223996 Toxoplasma Species 0.000 claims abstract description 27
- 241000699670 Mus sp. Species 0.000 claims abstract description 25
- 230000004520 agglutination Effects 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000011081 inoculation Methods 0.000 claims abstract description 7
- 239000000427 antigen Substances 0.000 claims description 16
- 102000036639 antigens Human genes 0.000 claims description 16
- 108091007433 antigens Proteins 0.000 claims description 16
- 210000000416 exudates and transudate Anatomy 0.000 claims description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 8
- 239000013049 sediment Substances 0.000 claims description 7
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 5
- 102000004142 Trypsin Human genes 0.000 claims description 5
- 108090000631 Trypsin Proteins 0.000 claims description 5
- 239000012588 trypsin Substances 0.000 claims description 5
- 206010003445 Ascites Diseases 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 206010039491 Sarcoma Diseases 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000004062 sedimentation Methods 0.000 claims 1
- 244000045947 parasite Species 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 230000009089 cytolysis Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 3
- 230000009172 bursting Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/947—Microorganisms using protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/822—Protozoa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8011261 | 1980-05-20 | ||
| FR8011261A FR2482980A1 (fr) | 1980-05-20 | 1980-05-20 | Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83343A1 true LU83343A1 (fr) | 1982-01-20 |
Family
ID=9242172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83343A LU83343A1 (fr) | 1980-05-20 | 1981-05-06 | Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose,et preparations ainsi obtenues |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4480043A (de) |
| EP (1) | EP0040572B1 (de) |
| JP (1) | JPS5739350A (de) |
| AT (1) | ATE4282T1 (de) |
| BE (1) | BE888855A (de) |
| DE (1) | DE3160694D1 (de) |
| FR (1) | FR2482980A1 (de) |
| IT (1) | IT1148013B (de) |
| LU (1) | LU83343A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2518407A1 (fr) * | 1981-12-17 | 1983-06-24 | Merieux Inst | Nouvel antigene pour la recherche de l'immunite toxoplasmique et son procede de preparation |
| BR8805647A (pt) | 1987-02-27 | 1989-10-31 | Gist Brocades Nv | Processo para clonagem molecular e expressao de genes que codificam para enzimas proteoliticas |
| GB8717863D0 (en) * | 1987-07-28 | 1987-09-03 | Acade Diagnostic Systems Sa Nv | Determination of antibodies |
| US4824666A (en) * | 1987-11-13 | 1989-04-25 | The United States Of America As Represented By The Secretary Of The Army | Method of large scale growth of toxoplasmic microorganisms |
| US4877726A (en) * | 1988-03-02 | 1989-10-31 | Research Institute Of Palo Alto Medical Foundation | Method for the detection of acute-phase toxoplasma infection |
| DE4302012C1 (de) * | 1993-01-26 | 1994-07-21 | Serosearch Gmbh Entwicklung Un | Immunologischer Test |
| JP2009122128A (ja) * | 2009-03-12 | 2009-06-04 | Shimadzu Corp | 移動相液体容器 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2226468A1 (en) * | 1973-04-18 | 1974-11-15 | Merieux Bd | Toxoplasma antigens - as agents for detecting toxoplasmosis by direct agglutination |
-
1980
- 1980-05-20 FR FR8011261A patent/FR2482980A1/fr active Granted
-
1981
- 1981-05-06 LU LU83343A patent/LU83343A1/fr unknown
- 1981-05-12 US US06/262,893 patent/US4480043A/en not_active Expired - Lifetime
- 1981-05-18 JP JP56073634A patent/JPS5739350A/ja active Granted
- 1981-05-18 IT IT48488/81A patent/IT1148013B/it active
- 1981-05-19 BE BE0/204224A patent/BE888855A/fr not_active IP Right Cessation
- 1981-05-19 DE DE8181400782T patent/DE3160694D1/de not_active Expired
- 1981-05-19 AT AT81400782T patent/ATE4282T1/de active
- 1981-05-19 EP EP81400782A patent/EP0040572B1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT1148013B (it) | 1986-11-26 |
| ATE4282T1 (de) | 1983-08-15 |
| US4480043A (en) | 1984-10-30 |
| FR2482980B1 (de) | 1984-03-16 |
| EP0040572B1 (de) | 1983-07-27 |
| JPH0136066B2 (de) | 1989-07-28 |
| DE3160694D1 (en) | 1983-09-01 |
| BE888855A (fr) | 1981-11-19 |
| FR2482980A1 (fr) | 1981-11-27 |
| JPS5739350A (en) | 1982-03-04 |
| EP0040572A1 (de) | 1981-11-25 |
| IT8148488A0 (it) | 1981-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bardawil et al. | Disseminated lupus erythematosus, scleroderma, and dermatomyositis as manifestations of sensitization to DNA-protein: I. An immunohistochemical approach | |
| EP1108057B1 (de) | Verfahren, werkzeuge und reagenzien für zelltrennung | |
| EP0194212B2 (de) | Verfahren zum Nachweis von agglutinierten Erythrozyten | |
| EP0015841A1 (de) | Agglutinationsteste zum Nachweis von Influenza-Viren, Reagenzien zur Durchführung dieser Teste, Verfahren zur Herstellung dieser Reagenzien, Verwendung dieser Reagenzien und Diagnosesatz mit diesen Reagenzien | |
| EP0311492B1 (de) | Immuntestsatz und -verfahren für ganze Zellen | |
| EP0040572B1 (de) | Verfahren zur Herstellung von Toxoplasmenbereitungen für die Toxoplasmosediagnose und die so hergestellten Bereitungen | |
| CA1166566A (fr) | Reactif de diagnostic des parasitoses et des allergies, procede de preparation de ce nouveau reactif et procede de diagnostic des parasitoses et des allergies a l'aide dudit | |
| EP0165830A1 (de) | Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren | |
| JPH055744A (ja) | う蝕原性菌の検出定量方法 | |
| WO1986005591A1 (fr) | Procede de determination immunologique d'une substance biologique dans un echantillon | |
| FR2515518A1 (fr) | Procede de production de preparations immunobiologiques applicables pour le diagnostic, la prevention et/ou le traitement d'infections par le candida guilliermondii, et preparations immunobiologiques en resultant | |
| FR2543300A1 (fr) | Reactif serologique | |
| FR2640143A1 (fr) | Anticorps polymerises, diriges contre des immunoglobulines - leur utilisation dans des tests de diagnostic | |
| FR2475737A1 (fr) | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede | |
| WO2007068830A1 (fr) | Distinction des meningites bacteriennes et virales | |
| EP0099812B1 (de) | Reagens zur Diagnose von Parasiten, Krankheiten und Allergien, Verfahren zur Herstellung desselben und Verfahren zur Diagnose von Parasiten, Krankheiten und Allergien mit Hilfe von diesem Reagens | |
| WO1987004457A1 (fr) | Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus | |
| FR2899337A1 (fr) | Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation. | |
| FR2684186A1 (fr) | Trousse pour le denombrement rapide des granulocytes, et procede utilisant ladite trousse. | |
| FR2674866A1 (fr) | Anticorps anti-ace et leurs applications a la detection specifique et eventuellement a la numeration des enterobacteries entieres, par une methode immunochimique. | |
| EP0072319B1 (de) | Gefärbte Toxoplasmen in einer stabilisierten Suspension und ihre Verwendung zum Nachweis von Toxoplasmosis | |
| EP0288388A1 (de) | Immundiagnostik von Protozoonparasitosen in Mollusken | |
| FR2771101A1 (fr) | Diagnostic serologique d'infection a neospora caninum | |
| FR2500164A1 (fr) | Procede de mise en evidence des antigenes de groupe sanguin a, b, h sur des cellules humaines en milieu liquide | |
| JPS61162753A (ja) | 歯周疾患診断用抗原調製品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DT | Application date | ||
| TA | Annual fee |